{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:19Z","timestamp":1791404599297,"version":"4.3.3"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":201,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015680","name":"Scotiabank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.japh.2024.102083","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T06:36:46Z","timestamp":1712039806000},"page":"102083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Medication utilization patterns in patients with post-COVID syndrome (PCS): Implications for polypharmacy and drug\u2013drug interactions"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-0650","authenticated-orcid":false,"given":"Henry Ukachukwu","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-8798","authenticated-orcid":false,"given":"Marie-Jos\u00e9e","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9144-092X","authenticated-orcid":false,"given":"Lesley K.","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-7120","authenticated-orcid":false,"given":"Nancy E.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2024.102083_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PHM.0000000000001910","article-title":"Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation","volume":"101","author":"Tabacof","year":"2022","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.japh.2024.102083_bib3","article-title":"A\u00a0patient-centered view of symptoms, functional impact, and priorities in post-COVID-19 syndrome: cross-sectional results from the Qu\u00e9bec Action Post-COVID cohort","author":"Mayo","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.japh.2024.102083_bib6","series-title":"COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19","year":"2022"},{"key":"10.1016\/j.japh.2024.102083_bib7","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis","volume":"55","author":"O\u2019Mahoney","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.japh.2024.102083_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.japh.2024.102083_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.911","article-title":"\u201cLONG COVID\u201d\u2014a hypothesis for understanding the biological basis and pharmacological treatment strategy","volume":"10","author":"Jarrott","year":"2022","journal-title":"Pharmacol Res Perspect"},{"issue":"23","key":"10.1016\/j.japh.2024.102083_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMp2304550","article-title":"Toward comprehensive care for long covid","volume":"388","author":"Nikolich","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"32","key":"10.1016\/j.japh.2024.102083_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jncimonographs\/lgh023","article-title":"Symptom clusters: the New Frontier in symptom management research","volume":"2004","author":"Miaskowski","year":"2004","journal-title":"JNCI Monogr"},{"key":"10.1016\/j.japh.2024.102083_bib12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/CIA.S66660","article-title":"Drug Burden Index in older adults: theoretical and practical issues","volume":"9","author":"Kouladjian","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"5","key":"10.1016\/j.japh.2024.102083_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"issue":"22","key":"10.1016\/j.japh.2024.102083_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000120","article-title":"Toward patient-centered care: a systematic review of how to ask questions that matter to patients","volume":"93","author":"Rosenzveig","year":"2014","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.japh.2024.102083_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/diagnostics8030066","article-title":"A brief questionnaire to assess post-exertional malaise","volume":"8","author":"Cotler","year":"2018","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.japh.2024.102083_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s11606-016-3703-5","article-title":"The primary care PTSD Screen for DSM-5 (PC-PTSD-5): Development and evaluation within a Veteran primary care sample","volume":"31","author":"Prins","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.japh.2024.102083_bib17","first-page":"921","article-title":"Development and validation of a voice-of-the-patient measure of cognitive concerns experienced by people living with HIV","volume":"30","author":"Askari","year":"2021","journal-title":"Qual life Res an Int J Qual life Asp Treat care Rehabil"},{"issue":"1","key":"10.1016\/j.japh.2024.102083_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"11","key":"10.1016\/j.japh.2024.102083_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40266-021-00895-x","article-title":"Quantifying anticholinergic burden and sedative load in older adults with polypharmacy: a systematic review of risk scales and Models","volume":"38","author":"Al Rihani","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.japh.2024.102083_bib22","author":"Singh"},{"issue":"2","key":"10.1016\/j.japh.2024.102083_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clpt.2006.04.014","article-title":"Lopinavir\/ritonavir reduces lamotrigine plasma concentrations in healthy subjects","volume":"80","author":"van der Lee","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.japh.2024.102083_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.mayocp.2023.04.007","article-title":"Post-COVID conditions","volume":"98","author":"Mueller","year":"2023","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.japh.2024.102083_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7525-7-67","article-title":"Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in Georgia","volume":"7","author":"Boneva","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.japh.2024.102083_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/pharmacy7040143","article-title":"Anticholinergic burden, sleep quality and health outcomes in Malaysian aged care home residents","volume":"7","author":"Kumar","year":"2019","journal-title":"Pharmacy"},{"key":"10.1016\/j.japh.2024.102083_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40266-023-01050-4","article-title":"The prognostic utility of anticholinergic burden scales: an integrative review and gap analysis","volume":"40","author":"Michael","year":"2023","journal-title":"Drugs Aging"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:31:37Z","timestamp":1737678697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1544319124001031"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102083","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication utilization patterns in patients with post-COVID syndrome (PCS): Implications for polypharmacy and drug\u2013drug interactions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102083"}}